Literature DB >> 20147388

Stimulation of HIV-1 replication in immature dendritic cells in contact with primary CD4 T or B lymphocytes.

Vincent Holl1, Ke Xu, Maryse Peressin, Alexandre Lederle, Marina Elizabeth Biedma, Maryse Delaporte, Thomas Decoville, Sylvie Schmidt, Géraldine Laumond, Anne-Marie Aubertin, Christiane Moog.   

Abstract

Sexual transmission is the major route of HIV-1 infection worldwide. Dendritic cells (DCs) from the mucosal layers are considered to be the initial targets of HIV-1 and probably play a crucial role in HIV-1 transmission. We investigated the role of cell-to-cell contact between HIV-1-exposed immature DCs and various lymphocyte subsets in the stimulation of HIV-1 replication. We found that HIV-1 replication and production in DCs were substantially enhanced by the coculture of DCs with primary CD4 T or nonpermissive B lymphocytes but not with primary activated CD8 T lymphocytes or human transformed CD4 T lymphocytes. Most of the new virions released by cocultures of HIV-1-exposed immature DCs and primary B lymphocytes expressed the DC-specific marker CD1a and were infectious for both immature DCs and peripheral blood mononuclear cells (PBMCs). Cocultured DCs thus produced large numbers of infectious viral particles under these experimental conditions. The soluble factors present in the supernatants of the cocultures were not sufficient to enhance HIV-1 replication in DCs, for which cell-to-cell contact was required. The neutralizing monoclonal antibody IgG1b12 and polyclonal anti-HIV-1 sera efficiently blocked HIV-1 transfer to CD4 T lymphocytes but did not prevent the increase in viral replication in DCs. Neutralizing antibodies thus proved to be more efficient at blocking HIV-1 transfer than previously thought. Our findings show that HIV-1 exploits DC-lymphocyte cross talk to upregulate replication within the DC reservoir. We provide evidence for a novel mechanism that may facilitate HIV-1 replication and transmission. This mechanism may favor HIV-1 pathogenesis, immune evasion, and persistence.

Entities:  

Mesh:

Year:  2010        PMID: 20147388      PMCID: PMC2863763          DOI: 10.1128/JVI.01567-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

Review 1.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

2.  Multifocal structure of the T cell - dendritic cell synapse.

Authors:  Cédric Brossard; Vincent Feuillet; Alain Schmitt; Clotilde Randriamampita; Maryse Romao; Graça Raposo; Alain Trautmann
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

3.  Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells.

Authors:  Vincent Holl; Maryse Peressin; Thomas Decoville; Sylvie Schmidt; Susan Zolla-Pazner; Anne-Marie Aubertin; Christiane Moog
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 4.  Dendritic cells in viral pathogenesis: protective or defective?

Authors:  Gabriele Pollara; Antonia Kwan; Philippa J Newton; Matthew E Handley; Benjamin M Chain; David R Katz
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

5.  Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection.

Authors:  Rebecca D Wiley; Suryaram Gummuluru
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

6.  Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer.

Authors:  Arnaud Moris; Anthony Pajot; Fabien Blanchet; Florence Guivel-Benhassine; Margarita Salcedo; Olivier Schwartz
Journal:  Blood       Date:  2006-05-04       Impact factor: 22.113

7.  Stimulation of cell surface CCR5 and CD40 molecules by their ligands or by HSP70 up-regulates APOBEC3G expression in CD4(+) T cells and dendritic cells.

Authors:  Jeffrey Pido-Lopez; Trevor Whittall; Yufei Wang; Lesley A Bergmeier; Kaboutar Babaahmady; Mahavir Singh; Thomas Lehner
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

8.  Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.

Authors:  Kathryn S Jones; Cari Petrow-Sadowski; Ying K Huang; Daniel C Bertolette; Francis W Ruscetti
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

9.  Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission.

Authors:  Stefanie Sowinski; Clare Jolly; Otto Berninghausen; Marco A Purbhoo; Anne Chauveau; Karsten Köhler; Stephane Oddos; Philipp Eissmann; Frances M Brodsky; Colin Hopkins; Björn Onfelt; Quentin Sattentau; Daniel M Davis
Journal:  Nat Cell Biol       Date:  2008-01-13       Impact factor: 28.824

10.  HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk.

Authors:  Héla Saïdi; Marie-Thérèse Melki; Marie-Lise Gougeon
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

View more
  7 in total

1.  Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.

Authors:  Caitlin M Miller; Hisashi Akiyama; Luis M Agosto; Ann Emery; Chelsea R Ettinger; Ronald I Swanstrom; Andrew J Henderson; Suryaram Gummuluru
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection.

Authors:  Ines Frank; Melissa Robbiani
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

3.  Dendritic cell-lymphocyte cross talk downregulates host restriction factor SAMHD1 and stimulates HIV-1 replication in dendritic cells.

Authors:  Bin Su; Marina Elizabeth Biedma; Alexandre Lederle; Maryse Peressin; Mélanie Lambotin; Alizé Proust; Thomas Decoville; Sylvie Schmidt; Géraldine Laumond; Christiane Moog
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

4.  Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.

Authors:  Bin Su; Maryse Peressin; Camille Ducloy; Julien Penichon; Luzia M Mayr; Géraldine Laumond; Sylvie Schmidt; Thomas Decoville; Christiane Moog
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-10       Impact factor: 2.205

5.  HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.

Authors:  F Forouzanfar; S Ali; C Wallet; M De Rovere; C Ducloy; H El Mekdad; M El Maassarani; A Aït-Ammar; J Van Assche; E Boutant; F Daouad; F Margottin-Goguet; C Moog; C Van Lint; C Schwartz; O Rohr
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

6.  Localization of infection in neonatal rhesus macaques after oral viral challenge.

Authors:  Roslyn A Taylor; Michael D McRaven; Ann M Carias; Meegan R Anderson; Edgar Matias; Mariluz Araínga; Edward J Allen; Kenneth A Rogers; Sandeep Gupta; Viraj Kulkarni; Samir Lakhashe; Ramon Lorenzo-Redondo; Yanique Thomas; Amanda Strickland; Francois J Villinger; Ruth M Ruprecht; Thomas J Hope
Journal:  PLoS Pathog       Date:  2021-11-18       Impact factor: 6.823

Review 7.  HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells.

Authors:  Charles R Rinaldo
Journal:  Scientifica (Cairo)       Date:  2013-05-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.